ISRCTN50086114
Completed
Not Applicable
A multicentre, prospective, randomised study to determine the effects of an exercise managed intervention (ARTEMIStudy)
Aging, Rehabilitation & Geriatric Care Research Centre (Canada)0 sites720 target enrollmentFebruary 11, 2010
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Aging, Rehabilitation & Geriatric Care Research Centre (Canada)
- Enrollment
- 720
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male or female
- •2\. Aged 18 to 70 years
- •3\. Presents with metabolic syndrome as defined by having SBP greater than 130 mmHg and/or DBP greater than 85 mmHg and any two of the following criteria:
- •3\.1\. Abdominal obesity (waist circumference greater than 102 cm in males; greater than 88 cm in females)
- •3\.2\. Fasting triglycerides greater than 1\.695 mmol/L
- •4\. Low HDL cholesterol: males less than 1\.04 mmol/L; females less than 1\.29 mmol/L
- •5\. Fasting glucose greater than 5\.60 mmol/
Exclusion Criteria
- •Any patient who:
- •1\. Has an in\-clinic mean SBP greater than or equal to 180 mmHg and/or DBP greater than or equal to 110 mmHg
- •2\. Has a history of myocardial infarction, angioplasty, coronary artery bypass, or cerebrovascular ischaemia/stroke
- •3\. Has symptomatic congestive heart failure
- •4\. Has atrial flutter
- •5\. Has uncontrolled hypertension
- •6\. Has unstable angina
- •7\. Has unstable pulmonary disease (e.g., asthma or obstructive lung disease)
- •8\. Uses medications known to affect heart rate (e.g., beta\-blockers)
- •9\. Has second or third degree heart block
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A Study to evaluate the efficacy and safety of folic acid plus cyanocobalamin plus pyridoxine as an adjuvant to Recombinant Human Epoetin Alpha (r-HuEPO) therapy in patients with anaemia of End stage renal disease (ESRD).Health Condition 1: D631- Anemia in chronic kidney diseaseCTRI/2010/091/000652Dr Narendra DedhiaParakh HospitalGhatkopar(E)Mumbai - 400 077, Maharashtra50
Completed
Phase 4
*A prospective randomized multicenter study to demonstrate the superiority of the Barricaid® to discectomy for primary lumbar disc herniation*: Extended Follow-Up of the Barricaid® Annular Closure Device (ACD) Randomized Control Trial (RCT) Postmarket Cohort for Lumbar Disc Herniation and Interaction with Other Risk Factorslumbar disc herniationsciatica100432371004154310009720NL-OMON55882Intrinsic Therapeutics, GmbH66
Not yet recruiting
Phase 4
To compare effectiveness, safety and tolerability of Lulican shampoo versus ketoconazole shampoo, in patients having scalp dermatitis.Health Condition 1: L210- Seborrhea capitisCTRI/2021/09/036865Anisha Clinic
Recruiting
Not Applicable
Comparison of IVF-ET outcomes with GnRH antagonist started either on stimulation day 1 and 6 vs. conventional GnRH agonist long protocol in patients with polycystic ovary syndromeEndocrine, nutritional and metabolic diseaseKCT0000157Seoul National University Hospital267
Completed
Not Applicable
A prospective randomised, multicentre trial to assess the impact of laboratory based rapid diagnosis on outcome in patients with Blood Stream InfectionsTopic: InfectionSubtopic: Infection (all Subtopics)Disease: Infectious diseases and microbiologyInfections and InfestationsISRCTN97107018orth Bristol NHS Trust (UK)4,536